Pulling SEC filings + quote and writing the call…

CAMDEN NATIONAL CORP
Next earnings Jul 27, 2026 · consensus $1.30 EPS, $67.5M rev
Last earnings +0.5% on 2026-04-28
Solid New England community bank digesting a sizable acquisition at a fair, not cheap, ~1.3x book and 13.8x earnings — own, don't chase.
Diluted EPS $3.84 · FY2025
Middling fundamentals offset by an attractive price (~169% below fair value) — worth a look on the value angle.
Camden National's FY2025 results are dominated by a closed acquisition: total assets jumped 20.1% to $6.97B, loans rose ~21% to $4.97B, goodwill nearly doubled to $151.5M and core deposit intangibles ballooned from $0.4M to $42.6M, with $9.3M of explicit M&A costs and a 16% jump in share count to 16.9M. The deal is working at the top line — net interest income surged from $132.5M to $203.3M and non-interest income climbed to $52.5M — but the cost of getting there shows up everywhere: provision for credit losses swung from a $0.4M credit to a $22.3M charge (Day-1 CECL on acquired loans is the most plausible read given the loan growth), salaries jumped 25%, CDI amortization ran $5.9M, and a $10.3M loss on securities sales suggests a balance-sheet restructuring around the deal. Diluted EPS still grew, but only +6.1% to $3.84 because earnings were spread across many more shares.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $32.0M | $33.3M | $33.6M | $35.7M | $41.7M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $69.0M | $61.4M | $43.4M | $53.0M | $65.2M |
| Diluted EPS | $4.60 | $4.17 | $2.97 | $3.62 | $3.84 |
| Net margin | 216.0% | 184.6% | 129.2% | 148.5% | 156.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Reg FD investor disclosure (likely conference/dividend slide); no financial change
Annual meeting voting results filed; routine governance disclosure
Officer/director change disclosed; leadership transition, no financial impact
Q1 2026 10-Q: equity $697M, loans $4.97B; capital build continues
Q1 2026 earnings release; post-Northway run-rate continues to lift NII
2026 proxy: routine board slate and say-on-pay; no governance red flags
Other-event disclosure (Item 8.01); informational, no material P&L change
FY25 10-K: NI $65M, assets $6.97B (+20%); first full year with Northway
Q4/FY25 earnings: EPS $3.84, NII $203M (+54%), driven by Northway add
Sources: SEC EDGAR (CIK 0000750686, latest 10-Q filed 2026-05-07) · EODHD · analysis by claude-code · as of 6/25/2026, 2:42:31 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-06-18 | Maxwell Raina Director | Award | 279.00 @ $51.49 | $14.4K |
| 2026-06-18 | Hatfield Rebecca Director | Award | 170.00 @ $51.49 | $8.75K |
| 2026-06-18 | Soderberg Carl John Director | Award | 308.00 @ $51.49 | $15.9K |
| 2026-06-18 | Haynes Larry K Director | Award | 279.00 @ $51.49 | $14.4K |
| 2026-06-01 | Soderberg Carl John Director | Award | 919.00 | |
| 2026-06-01 | McCarthy Marie J Director | Award | 919.00 | |
| 2026-06-01 | SAWYER ROBIN A Director | Award | 919.00 | |
| 2026-06-01 | Maxwell Raina Director | Award | 919.00 |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1044 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.